Y10S 424/80
Antibody or fragment thereof whose amino acid sequence is disclosed in whole
Official title: Antibody or fragment thereof whose amino acid sequence is disclosed in whole or in part
Y10S424/80 (Antibody or fragment thereof whose amino acid sequence is disclosed in whole) appears on 60 US grants and 49 published applications in this corpus.
Search patents in Y10S- Granted patents
- 60
- Published applications
- 49
- Assignees
- 36
- Inventors
- 82
- Latest grant
- 20 Oct 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 1 | 4 |
| 2004 | 6 | 6 |
| 2005 | 1 | 7 |
| 2006 | 2 | 7 |
| 2007 | 0 | 0 |
| 2008 | 6 | 3 |
| 2009 | 8 | 2 |
| 2010 | 1 | 3 |
| 2011 | 2 | 2 |
| 2012 | 5 | 3 |
| 2013 | 2 | 1 |
| 2014 | 1 | 4 |
| 2015 | 4 | 2 |
| 2016 | 2 | 2 |
| 2017 | 1 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- DNA molecules encoding antibodies to tau and methods of making thereof20 Oct 2020US 10,808,027 B2Eli Lilly and Company
- Antibodies to tau and methods of treatment therewith3 Jul 2018US 10,011,653 B2Eli Lilly and Company
- Methods of treating a tauopathy3 Oct 2017US 9,777,058 B2iPierian, Inc.
- Antibodies to tau and uses thereof27 Dec 2016US 9,527,909 B2Eli Lilly and Company
- Methods of treating a tauopathy20 Sep 2016US 9,447,180 B2iPierian, Inc.
- Antibodies to tau and uses thereof20 Sep 2018US 2018/0265577 A1Eli Lily and Company
- Antibodies to tau and uses thereof20 Apr 2017US 2017/0107278 A1Eli Lilly and Company
- Methods of treating a tauopathy8 Dec 2016US 2016/0355578 A1iPierian, Inc.
- Antibodies to tau and uses thereof1 Sep 2016US 2016/0251420 A1Eli Lilly and Company
- Methods of treating a tauopathy20 Aug 2015US 2015/0232544 A1iPierian, Inc.
Most cited
By later US patents
- Recombinant altered antibodies and methods of making altered antibodies1,968US 5,225,539 AMedical Research Council · 1993
- Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma744US 5,736,137 AIDEC Pharmaceuticals Corporation · 1998
- Polypeptide linkers for production of biosynthetic proteins555US 5,258,498 ACreative BioMolecules, Inc. · 1993
- Human antibodies that bind human TNF.alpha.451US 6,090,382 ABASF SE · 2000
- Biosynthetic antibody binding sites393US 5,132,405 ACreative BioMolecules, Inc. · 1992